298 related articles for article (PubMed ID: 10880752)
1. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
Blair A; Sutherland HJ
Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
[TBL] [Abstract][Full Text] [Related]
2. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-.
Blair A; Hogge DE; Sutherland HJ
Blood; 1998 Dec; 92(11):4325-35. PubMed ID: 9834239
[TBL] [Abstract][Full Text] [Related]
3. CD133 (AC133) expression on AML cells and progenitors.
Vercauteren SM; Sutherland HJ
Cytotherapy; 2001; 3(6):449-59. PubMed ID: 11953029
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
Sutherland HJ; Blair A; Zapf RW
Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
Bradbury DA; Zhu YM; Russell NH
Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652
[TBL] [Abstract][Full Text] [Related]
6. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.
Moore S; Haylock DN; Lévesque JP; McDiarmid LA; Samels LM; To LB; Simmons PJ; Hughes TP
Blood; 1998 Oct; 92(7):2461-70. PubMed ID: 9746786
[TBL] [Abstract][Full Text] [Related]
8. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
9. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
Hassan HT; Zander A
Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
[TBL] [Abstract][Full Text] [Related]
10. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo.
Blair A; Hogge DE; Ailles LE; Lansdorp PM; Sutherland HJ
Blood; 1997 May; 89(9):3104-12. PubMed ID: 9129012
[TBL] [Abstract][Full Text] [Related]
11. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
12. CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease.
Scolnik MP; Morilla R; de Bracco MM; Catovsky D; Matutes E
Leuk Res; 2002 Jul; 26(7):615-9. PubMed ID: 12008077
[TBL] [Abstract][Full Text] [Related]
13. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
15. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia.
Terpstra W; Prins A; Ploemacher RE; Wognum BW; Wagemaker G; Löwenberg B; Wielenga JJ
Blood; 1996 Mar; 87(6):2187-94. PubMed ID: 8630378
[TBL] [Abstract][Full Text] [Related]
16. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture.
Terpstra W; Ploemacher RE; Prins A; van Lom K; Pouwels K; Wognum AW; Wagemaker G; Löwenberg B; Wielenga JJ
Blood; 1996 Sep; 88(6):1944-50. PubMed ID: 8822911
[TBL] [Abstract][Full Text] [Related]
17. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
[TBL] [Abstract][Full Text] [Related]
19. Detection and clinical significance of human acute myeloid leukaemia progenitors capable of long-term proliferation in vitro.
Sutherland H; Blair A; Vercauteren S; Zapf R
Br J Haematol; 2001 Aug; 114(2):296-306. PubMed ID: 11529847
[TBL] [Abstract][Full Text] [Related]
20. Characterization of acute lymphoblastic leukemia progenitor cells.
Cox CV; Evely RS; Oakhill A; Pamphilon DH; Goulden NJ; Blair A
Blood; 2004 Nov; 104(9):2919-25. PubMed ID: 15242869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]